• TOP TRENDING
  • LATEST HEADLINES
  • TOPICS
  • REGIONS
  • SOCIAL FEEDS
  • VTL News App
  • CONTACT US
Menu
  • TOP TRENDING
  • LATEST HEADLINES
  • TOPICS
  • REGIONS
  • SOCIAL FEEDS
  • VTL News App
  • CONTACT US
Search
Login
Search
Close
  • TOP TRENDING
  • LATEST HEADLINES
  • TOPICS
  • REGIONS
  • SOCIAL FEEDS
  • VTL News App
  • CONTACT US
Menu
  • TOP TRENDING
  • LATEST HEADLINES
  • TOPICS
  • REGIONS
  • SOCIAL FEEDS
  • VTL News App
  • CONTACT US

[breadcrumb]

Categories

The Conversation

[breadcrumb]

Medical devices

How Theranos’ faulty blood tests got to market – and what that shows about gaps in FDA regulation

October 8, 2021 No Comments

One of the most high-profile trials of the year is underway to decide whether Theranos founder Elizabeth Holmes defrauded patients and investors. Her blood testing startup, once valued at almost US$10 billion, was based on a seemingly revolutionary premise. Company executives promised investors, and later business partners and patients, that

 5,881 Views

Continue Reading Post
LOAD MORE NEWS

How Theranos’ faulty blood tests got to market – and what that shows about gaps in FDA regulation

October 8, 2021 No Comments

One of the most high-profile trials of the year is underway to decide whether Theranos founder Elizabeth Holmes defrauded patients and investors. Her blood testing

 5,881 Views

Read More »
Facebook Twitter Instagram Youtube

Powerd By AppVerticals.
© 2022 VTL News. All Rights Reserved.
VTL News App | Privacy Policy | Sitemap